174 related articles for article (PubMed ID: 9051859)
1. Growth factors and bone formation in osteoporosis: roles for IGF-I and TGF-beta.
Marie P
Rev Rhum Engl Ed; 1997 Jan; 64(1):44-53. PubMed ID: 9051859
[TBL] [Abstract][Full Text] [Related]
2. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
3. Bone matrix insulin-like growth factor (IGF)-I, IGF-II and transforming growth factor (TGF)-beta1 levels in men and postmenopausal women with osteoporosis: lack of association with circulating growth factors and bone mineral density.
Georgescu C; Seck T; Diel I; Minne H; Duncea I; Pfeilschifter J
Rev Med Chir Soc Med Nat Iasi; 2004; 108(2):281-6. PubMed ID: 15688799
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone, insulin-like growth factors, and the senescent skeleton: Ponce de Leon's Fountain revisited?
Rosen CJ
J Cell Biochem; 1994 Nov; 56(3):348-56. PubMed ID: 7876328
[TBL] [Abstract][Full Text] [Related]
5. Skeletal unloading induces biphasic changes in insulin-like growth factor-I mRNA levels and osteoblast activity.
Drissi H; Lomri A; Lasmoles F; Holy X; Zerath E; Marie PJ
Exp Cell Res; 1999 Sep; 251(2):275-84. PubMed ID: 10471313
[TBL] [Abstract][Full Text] [Related]
6. Osteogenic growth peptide effects on primary human osteoblast cultures: potential relevance for the treatment of glucocorticoid-induced osteoporosis.
Spreafico A; Frediani B; Capperucci C; Leonini A; Gambera D; Ferrata P; Rosini S; Di Stefano A; Galeazzi M; Marcolongo R
J Cell Biochem; 2006 Jul; 98(4):1007-20. PubMed ID: 16795077
[TBL] [Abstract][Full Text] [Related]
7. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men.
Riggs BL; Khosla S; Melton LJ
J Bone Miner Res; 1998 May; 13(5):763-73. PubMed ID: 9610739
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of glucocorticoid action in bone cells.
Delany AM; Dong Y; Canalis E
J Cell Biochem; 1994 Nov; 56(3):295-302. PubMed ID: 7876321
[TBL] [Abstract][Full Text] [Related]
9. Growth factor stimulation of bone healing. Effects on osteoblasts, osteomies, and implants fixation.
Lind M
Acta Orthop Scand Suppl; 1998 Oct; 283():2-37. PubMed ID: 9856074
[TBL] [Abstract][Full Text] [Related]
10. Growth factors to stimulate bone formation.
Baylink DJ; Finkelman RD; Mohan S
J Bone Miner Res; 1993 Dec; 8 Suppl 2():S565-72. PubMed ID: 8122528
[TBL] [Abstract][Full Text] [Related]
11. [Physiopathology behind age-related bone loss. New insight in the mechanisms of cellular and molecular biology].
Kassem MS; Mosekilde L; Eriksen EF
Ugeskr Laeger; 1999 Oct; 161(41):5663-6. PubMed ID: 10565234
[No Abstract] [Full Text] [Related]
12. Transforming growth factor-beta prevents osteoblast apoptosis induced by skeletal unloading via PI3K/Akt, Bcl-2, and phospho-Bad signaling.
Dufour C; Holy X; Marie PJ
Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E794-801. PubMed ID: 18378961
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
14. Systemically administered rhBMP-2 promotes MSC activity and reverses bone and cartilage loss in osteopenic mice.
Turgeman G; Zilberman Y; Zhou S; Kelly P; Moutsatsos IK; Kharode YP; Borella LE; Bex FJ; Komm BS; Bodine PV; Gazit D
J Cell Biochem; 2002; 86(3):461-74. PubMed ID: 12210753
[TBL] [Abstract][Full Text] [Related]
15. Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor bioregulation systems in MG-63 human osteosarcoma cells.
Tenta R; Sourla A; Lembessis P; Koutsilieris M
Anticancer Res; 2006; 26(1A):283-91. PubMed ID: 16475708
[TBL] [Abstract][Full Text] [Related]
16. Decreased DNA synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation.
Marie PJ; de Vernejoul MC; Connes D; Hott M
J Clin Invest; 1991 Oct; 88(4):1167-72. PubMed ID: 1918371
[TBL] [Abstract][Full Text] [Related]
17. Effects of exercise training on bone remodeling, insulin-like growth factors, and bone mineral density in postmenopausal women with and without hormone replacement therapy.
Milliken LA; Going SB; Houtkooper LB; Flint-Wagner HG; Figueroa A; Metcalfe LL; Blew RM; Sharp SC; Lohman TG
Calcif Tissue Int; 2003 Apr; 72(4):478-84. PubMed ID: 12574871
[TBL] [Abstract][Full Text] [Related]
18. Decreased TGF-beta1 and IGF-1 protein expression in rat embryo skull bone in folic acid-restricted diet.
Santoso MI; Rohman MS
J Nutr Biochem; 2006 Jan; 17(1):51-6. PubMed ID: 16111879
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone may maintain bone formation in hibernating black bears (Ursus americanus) to prevent disuse osteoporosis.
Donahue SW; Galley SA; Vaughan MR; Patterson-Buckendahl P; Demers LM; Vance JL; McGee ME
J Exp Biol; 2006 May; 209(Pt 9):1630-8. PubMed ID: 16621944
[TBL] [Abstract][Full Text] [Related]
20. Osteoblast-specific expression of insulin-like growth factor-1 in bone of transgenic mice induces insulin-like growth factor binding protein-5.
Rutter MM; Markoff E; Clayton L; Akeno N; Zhao G; Clemens TL; Chernausek SD
Bone; 2005 Feb; 36(2):224-31. PubMed ID: 15780948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
